Phosphodiesterase 3B (PDE3B) is an important component of insulin and cAMP-dependent signalling pathways. In order to study phosphorylation of PDE3B, we have used an adenoviral system to express recombinant flag-tagged PDE3B in primary rat adipocytes and H4IIE hepatoma cells. Phosphorylation of PDE3B after treatment of cells with insulin, cAMP-increasing agents, or the phosphatase inhibitor, calyculin A was analyzed by two-dimensional tryptic phosphopeptide mapping and mass spectrometry. We found that PDE3B is multisite phosphorylated in adipocytes and H4IIE hepatoma cells in response to all these stimuli. Several sites were identified; serine (S)273, S296, S421, S424/5, S474 and S536 were phosphorylated in adipocyte as well as H4IIE hepatoma cells whereas S277 and S507 were phosphorylated in hepatoma cells only. Several of the sites were phosphorylated by insulin as well as cAMP-increasing hormones indicating integration of the two signalling pathways upstream of PDE3B, maybe at the level of protein kinase B.
Introduction
Cyclic nucleotide phosphodiesterases (PDEs) constitute eleven families of cAMP and cGMP hydrolyzing enzymes. PDE3B, one of two members in the PDE3 family, is highly expressed in brown and white adipose tissue, liver and pancreatic-β cells [1] , and has been shown to have an important role in the regulation of lipid and glucose metabolism in intact cells as well as in vivo [2] . Although it is well established that insulin as well as hormones that increase cAMP induce activation of PDE3B in adipocytes and hepatocytes, mechanisms involved in the regulation of PDE3B have been studied mainly in adipocytes. Thus, insulin stimulation of adipocytes induces serine phosphorylation and activation of PDE3B which involves tyrosine phosphorylation of insulin receptor substrates (IRS), activation of phosphoinositide 3-kinase (PI3K), and generation of phosphatidylinositol 3,4/3,4,5 phosphate [3, 4] . Downstream of PI3K, protein kinase B (PKB) appears to be an important insulin-stimulated kinase phosphorylating PDE3B [5] [6] [7] . Stimulation of adipocytes with isoproterenol and other cAMP-increasing agents also leads to serine phosphorylation and activation of PDE3B which is believed to be important in feedback regulation of cAMP.
Regarding the identity of sites phosphorylated in PDE3B in response to hormone stimulation of cells, the results from adipocytes are incomplete and partly contradictory, and there is to our knowledge no information on the phosphorylation of the 135 kDa PDE3B in hepatocytes. Two-dimensional tryptic phosphopeptide mapping of endogenous PDE3B from primary rat adipocytes identified S302 (corresponding to S296 in mouse) as a major site phosphorylated in adipocytes in response to both insulin and isoproterenol [8] . In another study using a site-directed mutagenesis approach in 3T3-L1 mouse adipocytes, S273 was shown to be important for insulin-mediated activation of PDE3B whereas S296 was demonstrated to be important for isoproterenol but not insulin-mediated activation of the enzyme [7] . The small amount of phosphorylated protein/peptide that can be obtained from endogenous phospho-PDE3B is a limiting factor for detailed studies on PDE3B phosphorylation. In this work we have developed and used an adenoviral system to express flag-tagged PDE3B in primary rat adipocytes and cultured H4IIE hepatoma cells. We show that PDE3B in adipocytes as well as hepatocytes is subjected to multisite phosphorylation, and a number of new sites have been identified.
Materials and methods

Material
Dulbecco's modified Eagle medium (DMEM) and foetal calf serum (FBS) were obtained from GIBCO BRL (Praisley, UK); 32 Pi was purchased from Amersham Bioscience (Little Chalfont, UK); anti-flag M2 affinity gel and bovine serum albumin (BSA) from Sigma (Saint Louis, USA); calyculin A from Alexis Biochemicals (Läufelfingen, Switzerland); sequencing grade modified trypsin from Promega (Madison, USA); C 13 E 12 from Berol Kemi AB (Stenungssund, Sweden); insulin from Novo Nordisk (Copenhagen, Denmark); BCA protein assay reagent from Pierce (Rockford, USA); H4IIE rat hepatoma cells from ATCC (Manassas, USA); and Sprague-Dawley rats from B&K Universal (Stockholm, Sweden). OPC3911 was a kind gift from Otsuka America Pharmaceutical (Rockville, USA). The β-galactosidase adenovirus was kindly provided by Drs. C.B. Newgard and H. Mulder and the flag-tagged PDE3B adenovirus was produced as described by L. Harndahl et al. [9] . The PDE3B antibodies were polyclonal and raised in rabbit against the peptide CGYYGSGKMFRRPSLP from PDE3B.
Preparation, infection, stimulation and
32 Pi labeling of primary rat adipocytes Adipocytes were prepared from epididymal adipose tissue of 36-to 43-dayold male Sprague-Dawley rats according to Rodbell [10] , with modifications according to Honnor et al. [11] . The cells (12.5% cell suspension) were suspended in DMEM with 5% FBS and 0.5% BSA and infected with β-galactosidase adenovirus (Adβ-gal, 5.0 × 10 7 virus/ml) or murine flag-tagged PDE3B adenovirus (AdPDE3B, 6.5 × 10 7 virus/ml) for 6 or 14 h at 37°C. The infected cells were washed and subjected to subcellular fractionation as described by Simpson et al. [12] with modifications as described by Goransson et al. [13] , or resuspended in Krebs-Ringer medium pH 7.5, 25 mM HEPES, 200 nM adenosine, 2 mM glucose and 1% BSA (0.3-1.5 ml 10% cell suspension). For 32 Pi labeling, the medium was supplemented with 2.5% BSA, 600 μM KH 2 PO 4 (2-4 ml 10% cell suspension) and 32 Pi (0.2-0.5 mCi/ml). The resuspended cells were stimulated at 37°C, homogenized at room temperature in 0.6-2 ml of buffer A consisting 50 mM TES, pH 7.4, 250 mM sucrose, 1 mM EDTA, 0.1 mM EGTA, antipain (10 μg/ml), leupeptin (10 μg/ml) and pepstatin A (1 μg/ml), and placed on ice. Homogenates from labeled cells was centrifuged at 175,000 × g for 1 h at 4°C and the fat cake and supernatant removed. The crude membrane fraction was rehomogenized in 0.75-1 ml buffer A supplemented with 1% C 13 E 12 , 80 mM NaF and 80 mM NaCl, put on ice for 1 h and centrifuged (8000 × g, 10 min, 4°C). The supernatant was mixed with 50-70 μl packed anti-flag M2 affinity agarose for 2.5-4 h at 4°C. The gel was washed five times with 500 μl of buffer A and flag-PDE3B was either eluted by boiling the gel for 15 min with 90 μl of buffer A supplemented with 1.6% SDS and 1 mg/ml BSA, or by adding trypsin as described below.
32 Pi labeling of H4IIE hepatoma cells H4IIE hepatoma cells were propagated and maintained in DMEM medium supplemented with 10% FBS, and 2 mM glutamine. The cells (1 × 10 7 cells in 100 mm petri dishes) were infected with AdPDE3B (2 × 10 9 virus/ml) or Adβ-gal (2 × 10 9 virus/ml) in DMEM medium without serum for 3 h before the medium was supplemented with 10% FBS and cultured for another 45 h. After infection, H4IIE cells were washed 3 times with PBS and incubated for 16 h in DMEM without serum. The cells were then incubated for 2 h with serum-free DMEM containing 300 μM KH 2 PO 4 and 32 Pi (0.2 mCi/ml), before stimulation. The H4IIE cells were suspended in 3-4 ml 50 mM HEPES (pH 7.5), 250 mM sucrose, 1 mM EDTA, 10 mM pyrophosphate, 5 mM NaF, 100 mM NaCl, 1 mM Na 3 VO 4 , Roche protease inhibitor cocktail, and homogenized in a Dounce homogenizer containing 1% Nonidet P-40. Homogenates were sonicated (1 × 5 pulses, output 2, 30% cycle) at 4°C, kept on a rotator for 30 min at 4°C, and centrifuged (12,000 × g, 20 min, 4°C) to remove insoluble material. Protein was measured using BCA protein assay reagent with BSA as standard. Approximately 3-8 mg proteins isolated from H4IIE cells infected with Adβ-gal or AdPDE3B were immunoprecipitated with 50 or 150 μl of anti-flag M2 affinity gel overnight. The precipitate was washed four times and eluted by boiling in Laemmli sample buffer for further analysis.
2.4. Trypsinization, peptide extraction, and two-dimensional (2D) phosphopeptide mapping of tryptic 32 P-labeled flag-PDE3B from primary rat adipocytes and H4IIE hepatoma cells Pi-labeled PDE3B bound to anti-flag M2 affinity gel was trypsinized at 37°C for 16 h with shaking in 210 μl containing 48 mM ammonium bicarbonate, 48 μM HCl and 4.8 μg/ml trypsin. The tryptic digests were removed and dried by vacuum centrifugation. Gel bands of ∼ 1.5 × 6 mm containing approximately 200-300 ng immunoprecipitated PDE3B from H4IIE hepatoma cells were washed with HPLC grade water, HPLC grade methanol and finally with 50% acetonitrile (ACN) (750 μl/tube with gentle shaking for 2-3 min). The gel pieces were dried for 30 min in a SC 110A SpeedVac® Plus (ThermoSavant) and incubated in 80 μl containing 100 mM ammonium bicarbonate and 5.0 μg/ml trypsin at 37°C. After 3 h, additional trypsin was added to the final concentration of 9.0 μg/ml, and the gel pieces were incubated for 12 h at 37°C. The digest solution was transferred to a polypropylene tube and extracted with 60 μl of 0.1% TFA and 50% ACN for 30 min at 37°C with shaking. The extracts were evaporated under vacuum and analyzed with MS/MS analysis after nano-liquid chromatography separation or subjected to 2D tryptic phosphopeptide mapping exactly as described in [8] .
Mass spectrometry (MS) analysis of phosphorylated adipocyte PDE3B peptides from 2D tryptic phosphopeptide maps
Phosphopeptides from the 2D tryptic phosphopeptide maps (originating from 12 ml 10% adipocyte cell suspension) were scraped out and mixed with 200 μl 20% ACN and 0.1% formic acid for 10 min and subjected to an ultrasonic bath for 10 min. The samples were centrifuged (40,000×g for 20 min) and the supernatant vacuum centrifuged to complete dryness. The dried peptide fractions were dissolved in 8 μl 1% formic acid in H 2 O and 6 μl were subjected to High Performance Liquid Chromatography (HPLC)-tandem MS (MS/MS) analysis. In some cases, the remaining 2 μl was mixed with 1 μl MALDI matrix (5 mg alpha-cyano-4-hydroxycinnamic acid/ml in 50% ACN, 0.1% triflouroacetic acid) and spotted on MALDI target plates. During HPLC-MS/MS the peptides were separated on an Atlantis dC18 NanoEase column (0.075 × 150 mm, 3 μm particle size) connected to a CapLC pump coupled to a Q-ToF Ultima mass spectrometer (Waters UK Ltd., Manchester, UK), using a 40-min linear gradient from 6% ACN to 55% ACN in H 2 O, 0.1% formic acid with a flow rate of 0.25 μl/min. The samples spotted on MALDI target plates were analyzed using a Finnigan LTQ linear ion trap mass spectrometer equipped with a vMALDI ion source controlled by Excalibur 1.4 (Thermo Electron Corporation, San José, CA, USA). The instrument was set to perform an MS survey scan (m/z 900-2000) followed by MS/MS scans of the 15 most abundant ions in each sample and to automatically switch to MS 3 when detecting a neutral loss of 98 Da, thus performing both MS/MS and MS 3 on potential phosphopeptides. The acquired MS/MS data from the Q-Tof Ultima was converted to PKL files using ProteinLynx 2.2 (Waters UK Ltd., Manchester, UK). The PKL files were then searched using Mascot 2.0 (Matrix Science Ltd., London, UK). The tolerance for the precursor ion mass was set to 0.2 Da and the tolerance for the fragment ion mass was set to 0.1 Da. The data from the LTQ were processed using Bioworks Browser 3.2 (Thermo Electron Corporation, San José, CA, USA) and searched using the Sequest search algorithm incorporated in Bioworks Browser. The tolerance for both the precursor and fragment ion masses was set to 1 Da. All searches were performed against the Mus musculus subset of the NCBInr database, using cysteic acid and methionine sulfone as constant modification and phosphorylation of serine, threonine and tyrosine as variable modifications. The MS/MS spectra of identified phosphopeptides were then inspected manually to see if the identification was correct and to ensure correct assignation of phosphorylation sites.
MS analysis of flag-PDE3B extracted peptides from H4IIE hepatoma cells
Peptide extracts from flag-PDE3B isolated from H4IIE hepatoma cells were analyzed using a Micromass Q-TOF Ultima Global (Micromass, Manchester, UK) in electrospray mode interfaced with an Agilent HP1100 CapLC (Agilent Technologies, Palo Alto, CA) prior to the mass spectrometer. Five to eight microliters of each digest was loaded onto a Vydac C18 MS column (100 × 1.5 mm; Grace Vydec, Hesperia, CA) and chromatographic separation was performed at 0.1 ml/min using the following gradient: 0-10% B over 5 min; gradient from 10-40% B over 60 min; 40-95% B over 5 min; 95% B held over 5 min (solvent A: 0.2% formic acid in water; solvent B: 0.2% formic acid in ACN). Data were processed using the MassLynx software package (version 3.5) to generate peak list files prior to in-house licensed Mascot 1.8 search at http:// biospec.nih.gov (MatrixScience Ltd., London, UK). For ESI-MS/MS data, a tolerance of 1.0 Da was chosen for fragments. The combined NCBInr database was searched with species restriction of mammalia. Carbamidomethyl (C), oxidation (M), phospho (ST) and phospho (Y) were chosen as variable modifications.
Additional analytical procedures
Homogenates from adipocytes and flag-PDE3B immunoprecipitates from 32 Pi-labeled adipocytes and H4IIE hepatoma cells were boiled in Laemmli sample buffer and subjected to sodium dodecyl sulphate-polyacrylamide electrophoresis (SDS-PAGE), 7-8% acrylamide. The gel was either stained with Simply Blue™ safe stain (Invitrogen) for 15 min or analyzed by digital imaging (Fuji FLA-3000, Fuji Inc., Tokyo, Japan) for 32 Pi detection. The proteins were in some experiments electrotransferred to hybond-C membranes and incubated with PDE3B antibodies as described previously [14] . PDE3 activity and lipolysis were measured as previously described [15, 16] , in duplicate. The statistical significance of differences was counted using a paired Student's t-test. Results are presented as mean ± standard error of the mean (SEM).
Results
Characterization of recombinant PDE3B overexpressed in primary rat adipocytes and H4IIE hepatoma cells
Incubation of primary rat adipocytes with flag-PDE3B adenovirus (AdPDE3B) (6 or 14 h) resulted in overexpression of PDE3B (10-or 25-fold) compared to cells incubated with β-galactosidase adenovirus (Adβ-gal) (Figs. 1A-C) . Overexpression of PDE3B in H4IIE hepatoma cells after AdPDE3B infection (48 h) was 50-to 100-fold (Figs. 3A, B) . The recombinant PDE3B was characterized with regard to location, regulation and biological effects. Adipocytes expressing flag-PDE3B were subjected to subcellular fractionation, and as seen in Fig. 1C recombinant and endogenous PDE3B (from adipocytes infected with Adβ-gal) showed identical distribution between the different subcellular compartments. Adipocytes and H4IIE cells expressing flag-PDE3B were stimulated with insulin, cAMP-increasing agents (forskolin, isoproterenol or/and OPC3911) or a phosphatase inhibitor (calyculin A), and PDE3 activity was measured in the homogenates (endogenous PDE3B in adipocyte and H4IIE cells constituted 10% and 1% of total PDE3 activity, respectively, in all conditions). As shown in Figs. 2A and 3A flag-PDE3B was activated both in adipocytes and H4IIE cells stimulated with the different agents, as is the case for endogenous PDE3B [17] [18] [19] [20] . For the analysis of PDE3B phosphorylation in adipocytes and H4IIE cells expressing flag-PDE3B, cells were incubated with 32 Pi, and flag-PDE3B was immunoprecipitated using anti-flag M2 affinity gel. As shown in Figs. 2B and 3C, insulin, cAMP-increasing agents and calyculin A increased phosphorylation of flag-PDE3B as compared to non-stimulated adipocytes and H4IIE cells. This has previously been shown for endogenous PDE3B in adipocytes [8, 18, 19] , but to Primary rat adipocytes were incubated for 6 h with β-galactosidase adenovirus (Adβ-gal) or flag-PDE3B adenovirus (AdPDE3B), homogenized, and analyzed either by immunoblotting (20 μg protein = 2.7 μl PCV/lane) using anti-PDE3B antibodies (A) or by measuring PDE3 activity (B) (n = 7). (C) Primary rat adipocytes were infected for 14 h with Adβ-gal or AdPDE3B, and subjected to subcellular fractionation before PDE3 activity was measured (n = 4). PCV; packed cell volume, results are shown as mean ± SEM. our knowledge not for the 135 kDa PDE3B in hepatocytes. Finally, lipolysis was measured in AdPDE3B and Adβ-gal infected primary rat adipocytes to investigate the ability of flag-PDE3B to mediate regulation of lipolysis. As shown in Fig. 4 , lipolysis was lower in AdPDE3B infected cells as compared to Adβ-gal infected cells. Furthermore, in AdPDE3B infected cells insulin-induced inhibition of isoproterenol mediated lipolysis was enhanced. Thus, at 0.1 nM insulin isoproterenolinduced lipolysis was lowered by 24.0 ± 7.1% and 40.9 ± 4.2% (p = 0.0014) in Adβ-gal and AdPDE3B infected cells, respectively. At 0.3 nM insulin the lowering of lipolysis was 47.5 ± 7.3% and 55.8 ± 5.1% (p = 0.058) in Adβ-gal and AdPDE3B infected cells, respectively. In the following, flag-PDE3B phosphorylated in response to different agents in adipocytes and H4IIE cells were used as starting material for studies of PDE3B phosphorylation.
3.2. PDE3B is subjected to multisite phosphorylation in response to insulin, cAMP-increasing agents and calyculin A in primary rat adipocytes and H4IIE hepatoma cells
As a first step to study the sites phosphorylated in PDE3B in adipocytes and hepatoma cells, we generated 2D tryptic The ratios are presented as fold increase in comparison to control, mean ± SEM (n = 7 except for OPC and CalA n = 3, from the left p < 0.0023, p < 0.043, p < 0.14, p < 0.0077, p < 0.035). phosphopeptide maps of flag-PDE3B phosphorylated in response to different stimuli. Primary rat adipocytes and H4IIE cells expressing flag-PDE3B were labeled with 32 Pi and treated with insulin, cAMP-increasing agents, or calyculin A. Detergent-treated membrane fractions were applied to an anti-flag M2 affinity gel. After extensive washing flag-PDE3B attached to the anti-flag M2 affinity gel was subjected to trypsin digestion (adipocyte derived material) or eluted from the column (H4IIE cells and adipocyte derived material). Eluted PDE3B was subjected to SDS-PAGE, detected by autoradiography (seen in Figs. 2B and 3C) , cut out and digested with trypsin. The PDE3B tryptic phosphopeptides (tPP) from both adipocytes and H4IIE cells were separated in two dimensions using thin layer electrophoresis (TLE) and thin layer chromatography (TLC). Several tPPs denoted tPP1-13 were generated from the adipocyte PDE3B (Figs. 5A-E) and H4IIE cell PDE3B (Figs. 5G-J) in response to the different agents. Fig. 5F represents a summary of 40 adipocyte and H4IIE PDE3B maps showing a merged picture of the tPPs reproducibly observed with the different agents. tPP2, tPP3 and tPP8-12 appear to be present in all maps from adipocytes independent of the activating stimuli. On the other hand, tPP1, which is present after insulin as well as isoproterenol ± OPC3911 stimulation, is not present after calyculin A stimulation. Furthermore, tPP7 is present only in maps from adipocytes stimulated with isoproterenol ± OPC3911, and tPP4-6 and tPP13 appear only in maps from calyculin A stimulated cells. When comparing the two cell types, tPP2-6, tPP9-10 and tPP13 appear to be present in maps from adipocytes as well as H4IIE cells. The major differences between the adipocyte and H4IIE PDE3B maps are the lack of tPP1, tPP7 and tPP8 in the H4IIE maps. The lack of tPP1 can be explained by the fact that the tPP corresponding to tPP1 in PDE3B H4IIE maps contains one additional phosphorylation and two additional arginine (see MS/MS results below) which gives the peptide a different mobility during the TLE and TLC. Unfortunately we were not able to locate the H4IIE tPP corresponding to adipocyte tPP1 in the H4IIE maps. In the PDE3B maps generated from H4IIE cells, forskolin, which increases cAMP in the cell, and insulin interestingly produced similar PDE3B phosphorylation patterns (Figs. 5I vs. H) .
Identification of sites phosphorylated in PDE3B in primary rat adipocytes and in H4IIE hepatoma cells
In order to identify sites phosphorylated in PDE3B from primary rat adipocytes, we scraped out tPPs from 2D tPP maps of flag-PDE3B, in most cases originating from calyculin A or isoproterenol + OPC3911 stimulated adipocytes (Figs. 5D and E). The tPPs were identified using mass spectrometry (HPLC-MS/MS) as described in Materials and methods. To this end six out of the 13 tPPs summarised in Fig. 5F have been identified (Table 1 ). All identifications were performed using spectra from the Q-ToF Ultima. In most cases the phosphorylation site(s) of each peptide was unambiguously assigned. Flag-PDE3B tPP1- 6 were found to contain phosphate on S273, S296, S421, S424/ 5 (peptide phosphorylated on S421 and either S424 or S425), S474 and S536, respectively ( Table 1) . As shown in Figs. 5A-E, S273, S296 and S421 were phosphorylated in response to stimulation of rat adipocytes with insulin as well as isoproterenol ± OPC391 whereas S424/5, S474 and S536 were phosphorylated mainly in response to calyculin A.
To identify sites phosphorylated in hepatocyte PDE3B, flag-PDE3B expressing H4IIE cells were stimulated with insulin or calyculin A and the recombinant enzyme was immunoisolated with anti-flag M2 affinity gel and subjected to SDS-PAGE. The 135 kDa PDE3B band detected after staining with Simply Blue™ safe stain (Fig. 3B) was cut out and subjected to in-gel trypsin digestion. Digested PDE3B was analyzed using mass spectrometry (HPLC-MS/MS) as described in Materials and methods. As shown in Table 2 , insulin induces phosphorylation of S273, S277, S296 and S421. In addition to those sites calyculin A induces phosphorylation of S474, S507 and S536.
Discussion
In this work we have identified a number of new PDE3B phosphorylation sites, all of which are localized in the regulatory domain of the enzyme (Fig. 6A) . The results presented extensively extend the knowledge of PDE3B phosphorylation in adipocytes and are also, to our knowledge, the first report on phosphorylation of the 135 kDa PDE3B in hepatocytes (Table 2) . Previous studies on endogenous PDE3B phosphorylated in adipocytes indicated multisite phosphorylation of the enzyme; however, identification of several of the sites was not possible due to the limited amount of phosphorylated PDE3B [8, 19] . In order to generate sufficient amount of material for PDE3B site analysis, in this study mouse PDE3B was overexpressed in adipocytes as well as rat H4IIE cells. Importantly, the overexpressed PDE3B was carefully characterized with regard to localization, regulation and function. Thus, overexpressed PDE3B was localized to the same subcellular compartment as endogenous, i.e., in the plasma membrane and high-density membrane fraction. Other important arguments with regard to the relevance for our model are that the overexpressed PDE3B is activated in response to Flag-PDE3B from H4IIE hepatoma cells infected with AdPDE3B and stimulated with 100 nM insulin (Ins) for 10 min or 100 nM calyculin A (CalA) for 15 min were isolated by anti-flag agarose, and subjected to SDS-PAGE. The 135 kDa band seen in Fig. 3C was subjected to trypsin digestion and the peptides were identified. Average total sequence coverage for flag-PDE3B after tryptic analysis were 28, 35 and 44% in Ctrl, Ins and CalA treated samples respectively (n = 3 various stimuli in the same manner as the endogenous PDE3B and mediates regulation of lipolysis. Finally, we get similar results from both adipocytes and H4IIE cells regarding the phosphorylation of the overexpressed PDE3B which also support the relevance for the sites identified.
Multisite phosphorylation of PDE3B suggests complex and intricate regulatory mechanisms involving phosphorylation dependency with regard to docking with other proteins, control of catalytic activity, subcellular localization, and protein degradation. With regard to activity control, phosphorylation of S273 was previously shown to be important for insulininduced activation whereas S296 was shown to be important for isoproterenol-induced activation of PDE3B in 3T3-L1 adipocytes using a site-directed mutagenesis strategy [7] . In the present study, however, we show that both S273 and S296 are phosphorylated in response to insulin as well as isoproterenol. In agreement with these results, S302 (corresponding to S296 in mouse) in endogenous PDE3B was previously shown to be phosphorylated in response to insulin as well as isoproterenol stimulation of primary rat adipocytes [8] . As shown in the present work, insulin (Table 2) as well as forskolin induced phosphorylation of S296 in H4IIE hepatoma cells (Fig. 5I) , indeed supporting an important role for this site as a target for insulin as well as cAMP action. Also in 3T3-L1 adipocytes S296 as well as S273 seem to be important targets for insulininduced PDE3B phosphorylation. Thus, Onuma et al. [21] have demonstrated insulin-dependent interactions between PDE3B and 14-3-3 proteins in 3T3-L1 adipocytes, which was disrupted by adding PDE3B peptides phosphorylated at S296 or S273. All together these results support the importance of both S273 and S296 PDE3B phosphorylation in response to either insulin or isoproterenol in primary rat as well as mouse 3T3-L1 adipocytes. With regard to PDE3B interactions in addition to 14-3-3, we have shown insulin-dependent interactions in 3T3-L1 adipocytes between phosphorylated PDE3B and a number of insulin signalling components such as IRS-1, PI3K p85 and PKB (Ahmad et al., unpublished data). PDE3B has also been shown to interact with the insulin receptor in a hormonedependent manner in human adipocytes [22] and in a hormoneinsensitive manner with PI3Kγ in mouse heart [23] , caveolae in rat adipocytes [14] , and a 47 kDa protein of unknown function in 3T3-L1 adipocytes [24, 25] . The interactions of PDE3B with several other proteins both in a hormone sensitive and hormoneinsensitive manner are probably very important. We suggest that PDE3B is regulated by an intricate system of phosphorylations some of which are activity-controlling whereas others regulate interactions with other proteins.
Exactly which kinases are responsible for the phosphorylations of PDE3B is not known. The finding that some of the sites in adipocytes and hepatocytes, respectively, can be phosphorylated in response to a broad range of stimuli indicate integration of signalling pathways upstream of PDE3B, maybe at the level of PKB. Indeed, PKB, which has been suggested to be a PDE3B kinase, is known to be phosphorylated/activated both by insulin, β-adrenergic agonists and phosphatase inhibitors in adipocytes [26] [27] [28] , supporting a role for PKB in mediating, at least partly, the isoproterenol effect on PDE3B. This could thus give a mechanistic explanation to why isoproterenol and insulin induce phosphorylation of a set of sites that are the same. On the other hand, isoproterenol, but not insulin, induces the appearance of tPP7 in adipocyte PDE3B maps indicating the presence also of isoproterenol-dependent but PKB-independent control of PDE3B phosphorylation. Unfortunately, we have not been able to identify tPP7 (radio sequencing indicates that amino acid 3 and/or 4 is phosphorylated). We did not detect tPP7 in PDE3B maps from forskolin stimulated H4IIE cells which represents one of the few differences when comparing sites phosphorylated in PDE3B in adipocytes and hepatocytes. When performing a search for possible PKB phosphorylation sites within PDE3B using Scansite 2.0, which utilizes short sequence motifs to predict possible cell signalling interactions based on phage display and oriented peptide library [29] , we found, with medium stringency, four PKB phosphorylation sites with similar scores S273, S296, S474 and S378. Thus, three out of four sites localized within a consensus sequence for phosphorylation by PKB were identified in this work namely S273, S296 and S474 (Fig. 6B) .
Although one hypothesis is that isoproterenol mediates its effect via PKB at least to some extent, PDE3B could also be a direct target for PKA, a kinase previously shown to phosphorylate rat adipocyte PDE3B on S427 (corresponding to S421 in mouse) in vitro [30] . S421 is a site identified also in this work (phosphorylated by all stimuli) and is situated in a typical PKA phosphorylation consensus sequence (Fig. 6B) . In addition, three other sites situated in consensus sequences for phosphorylation by PKA appeared when performing a search using Scansite 2.0, namely S273, S274 and S296. Thus, S273 as well as S296 are potential targets for PKB as well as PKA catalyzed phosphorylations, which is interesting in the context of interplay between insulin and isoproterenol mediated regulation of PDE3B. In this perspective one should also have in mind that β-adrenergic agonists can mediate cAMP-dependent as well as cAMP-independent signalling events and cAMP-dependent signalling can be PKA-dependent as well as PKA-independent, the latter via Epac (GTP exchange factor activated by cAMP).
With regard to S277 (H4IIE cells), S507 (H4IIE cells), S424/425 (adipocytes and H4IIE-tPP4), and S536 (adipocytes and H4IIE cells), kinases and phosphatases involved in controlling the phosphorylation state of these sites are completely unknown. We have previously shown that PP2A has an important role in the phosphorylation and activation of PDE3B [19] . In this study it is interesting to observe that pretreatment of adipocytes and H4IIE cells with calyculin A, which inhibits PP1 and PP2A [19] , generates almost identical phosphorylation patterns of PDE3B in the two cell types. In a previous study it was also shown that pre-treatment of rat adipocytes with okadaic acid (a PP2A inhibitor) and calyculin A induced slightly different phosphorylation patterns of endogenous PDE3B which is in agreement with findings from overexpressed PDE3B (data not shown). Thus, the role for different phosphatases and kinases in the regulation of PDE3B phosphorylation will be further evaluated. Finally, we
have not yet been able to identify the sites phosphorylated in tPP7-13.
We conclude that PDE3B is subjected to multisite phosphorylation in response to hormones in adipocytes as well as hepatocytes, which was recently also reported for PDE3A [31] . The elucidation of the regulation of PDE3B phosphorylation is important as part of understanding the cAMP and insulin signalling networks in adipocytes and hepatocytes which play a key role in the regulation of lipolysis, glucose uptake and lipogenesis in adipocytes and glycogenolysis and glyconeogenesis in hepatocytes.
